Citadel Advisors
ASTH icon

Citadel Advisors’s Astrana Health ASTH Stock Holding History

Citadel Advisors’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$397K Sell
16,200
-2,100
-11% -$49.7K ﹤0.01% 9826
2025
Q4 		$454K Sell
18,300
-2,900
-14% -$77K ﹤0.01% 9261
2025
Q3 		$601K Sell
21,200
-10,600
-33% -$287K ﹤0.01% 8677
2025
Q2 		$791K Sell
31,800
-69,300
-69% -$1.95M ﹤0.01% 7592
2025
Q1 		$3.14M Buy
101,100
+79,100
+360% +$2.64M ﹤0.01% 4685
2024
Q4 		$694K Buy
22,000
+10,600
+93% +$503K ﹤0.01% 7853
2024
Q3 		$661K Buy
11,400
+6,600
+138% +$324K ﹤0.01% 7673
2024
Q2 		$195K Sell
4,800
-3,200
-40% -$127K ﹤0.01% 9979
2024
Q1 		$336K Buy
8,000
+3,500
+78% +$137K ﹤0.01% 9224
2023
Q4 		$172K Sell
4,500
-200
-4% -$6.66K ﹤0.01% 10178
2023
Q3 		$145K Sell
4,700
-1,400
-23% -$48.3K ﹤0.01% 10413
2023
Q2 		$193K Buy
6,100
+900
+17% +$30.9K ﹤0.01% 9950
2023
Q1 		$190K Sell
5,200
-3,700
-42% -$130K ﹤0.01% 10268
2022
Q4 		$263K Buy
8,900
+2,400
+37% +$77.2K ﹤0.01% 9599
2022
Q3 		$254K Sell
6,500
-400
-6% -$18.3K ﹤0.01% 9943
2022
Q2 		$266K Sell
6,900
-800
-10% -$30.4K ﹤0.01% 10091
2022
Q1 		$373K Sell
7,700
-16,400
-68% -$846K ﹤0.01% 10088
2021
Q4 		$1.77M Sell
24,100
-16,500
-41% -$1.36M ﹤0.01% 6529
2021
Q3 		$3.7M Buy
+40,600
New +$3.45M ﹤0.01% 4908

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Citadel Advisors's ASTH Position: Q1 2026 in Review

Citadel Advisors reduced its Astrana Health (ASTH) stake by 21% in Q1 2026, selling an estimated $154K and leaving 25,019 shares worth $613K. The position accounts for ﹤0.01% of the portfolio, ranked #8791.

Citadel Advisors first reported a position in ASTH in Q3 2018 and has held it in 22 quarters since. The position peaked at $10.3M in Q3 2022. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

  • Citadel Advisors held 25,019 shares of Astrana Health worth $613K as of Q1 2026.
  • Citadel Advisors sold 6,485 Astrana Health shares in Q1 2026, an estimated $154K.
  • Astrana Health made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #8791 holding.
  • Citadel Advisors first reported a position in Astrana Health in Q3 2018 and has held it in 22 quarters since.
  • Citadel Advisors's Astrana Health position peaked at $10.3M in Q3 2022.
  • 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.